U.S., March 4 -- ClinicalTrials.gov registry received information related to the study (NCT07445087) titled 'A Study of Takhzyro in Teenagers and Adults With Hereditary Angioedema (HAE) in South Korea' on Feb. 25.
Brief Summary: Takhzyro is an approved treatment for hereditary angioedema (HAE) in South Korea. HAE is a rare condition which causes sudden swelling under the skin and inside the body, like in the belly, throat, or genitals. The main aim of this study is to check how safe Takhzyro is in teenagers and adults with HAE in everyday medical care in South Korea. Another aim is to see how well Takhzyro works in everyday medical care.
The treatment of participants and any check-ups will be determined by the treating doctors according t...